Study groups | p value | ||
---|---|---|---|
CAE patients (n=56) | Control patients (n=44) | ||
TGF β1 (pg/ml) | 3250.40± 212.81 | 4851.21± 570.36 | 0.012 |
Fasting glucose (mg/dl) | 119.23 ± 5.96 | 124.39± 10.25 | 0.649 |
HbA1c (%) | 6.50± 0.18 | 6.16 ± 0.13 | 0.152 |
ALT (SGPT) (U/L) | 27.43/3.49 | 22.52/2.29 | 0.271 |
AST ( SGOT) (U/L) | 24.32/2.27 | 21.70/1.92 | 0.399 |
BUN (mg/dl) | 15.82±0.52 | 16.82±1.01 | 0.355 |
Creatine (mg/dl) | 0.92±0.03 | 0.86±0.03 | 0.290 |
WBC (103μl) | 8.44±0.35 | 7.932±0.37 | 0.322 |
Hct (%) | 40.94±0.69 | 38.78±0.76 | 0.040 |
Platelet (103μl) | 239.27±9.15 | 249.95±10.49 | 0.444 |
TSH (μu/ml) | 2.39±0.32 | 2.15±0.22 | 0.559 |